Try our Advanced Search for more refined results

PTAB Nixes 'Recycled' Bid For AIA Review Of Suboxone Patent

By Aaron Vehling (December 23, 2014, 2:32 PM EST) -- The Patent Trial and Appeal Board has rejected BioDelivery Sciences International's petition for review of Reckitt Benckiser Pharmaceuticals Inc.'s patent on the opiate addiction treatment Suboxone, ruling that the petition "recycled" arguments from the company's earlier petition for review of the same patent....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!